Advisory for the Bold: Turning Science Into Scalable Growth
Innovative Strategies
At Radion Advisory Group we help companies become investment-ready by aligning strategy and operations for scale. At the same time, we guide investors to the most promising areas within the radiotherapy ecosystem to optimize capital deployment.
What We Do
Radion Advisory Group specializes in helping companies and investors succeed across the radiotherapy and radiopharmaceutical landscape.
Investment Readiness for Companies
We work with emerging and growth-stage companies to ensure they are strategically and operationally prepared for investment. Our support spans corporate strategy, operational infrastructure, and commercialization planning—aligning scientific vision with executable business plans that investors can underwrite with confidence.
Strategic & Operational Execution
From early development through scale-up, we help teams build the processes, capabilities, and organizational discipline required to move efficiently from concept to value creation. Our approach is practical, data-driven, and grounded in real-world execution within regulated environments.
Investor Advisory & Market Intelligence
We partner with investors to identify the most attractive areas within the radiotherapy ecosystem, helping them understand where science, clinical demand, and market dynamics intersect. Our insights support smarter capital allocation and maximize the likelihood of strong, risk-adjusted returns.
Bridging Science, Strategy, and Capital
At our core, we act as a bridge—connecting innovative science with sound strategy and informed investment decisions to accelerate progress across the radiotherapy space.
Why Radion?
We Understand Both Sides of the Table
Radion brings a rare combination of deep domain expertise and investment perspective. We work with companies preparing for capital and with investors deploying it—giving us a clear view of what drives conviction, valuation, and long-term success.
Built for the Radiotherapy Ecosystem
Radiotherapy and radiopharmaceuticals are complex, highly regulated, and capital-intensive. Radion is purpose-built for this space. Our experience spans science, operations, and commercialization, allowing us to navigate technical risk while keeping strategy and execution aligned.
Practical, Execution-Focused Guidance
We don’t deliver generic frameworks. We provide actionable, execution-ready guidance that helps companies move forward and investors make informed decisions. Every engagement is grounded in real-world constraints and measurable outcomes.
Trusted Partner from Strategy to Capital
Whether preparing a company for its next financing or helping investors identify where to place capital, Radion serves as a trusted, objective partner focused on long-term value creation.
Whether you’re a startup advancing toward IND-enabling milestones, a scaling biotech building clinical and commercial infrastructure, or an investor seeking to strengthen portfolio performance, Radion delivers tailored strategies and hands-on execution to drive outcomes that matter.